Reuter, Susanne
Woelber, Linn
Trepte, Constantin C.
Perez, Daniel
Zapf, Antonia
Cevirme, Sinan
Mueller, Volkmar
Schmalfeldt, Barbara
Jaeger, Anna
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 10 August 2021
Accepted: 15 November 2021
First Online: 27 December 2021
Declarations
:
: SR declares no conflict of interest; LW declares research support and personal fees from Medac oncology, MSD, and Roche, as well as personal fees from Pfizer, Tesaro, and GSK; CT declares no conflict of interest; DP declares services to Intuitive Surgical on a honorary basis; AZ declares no conflict of interest; SC declares no conflict of interest; VM declares speaker honoraria from Amgen, Astra Zeneca, Daiichi-Sankyo, Eisai, Pfizer, MSD, Novartis, Roche, Teva, Seattle Genetics and consultancy honoraria from Genomic Health, Hexal, Roche, Pierre Fabre, Amgen, ClinSol, Novartis, MSD, Daiichi-Sankyo, Eisai, Lilly, Tesaro, and Nektar, as well as institutional research support from Novartis, Roche, Seattle Genetics, and Genentech; BS declares no conflict of interest; AJ declares personal fees from Astra Zeneca, Molecular Health, GSK, Roche, Clovis Oncology, and MSD.
: Ethics Committee of the Medical Board Hamburg (PV190504).
: Consent was obtained from all patients.
: All authors read and agreed to the final version of this manuscript.